← FDA Drug Approvals (Drugs@FDA)
FELBAMATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TARO · Approved 2017-04-20
Drug application
- FDA Application #
ANDA207093- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FELBAMATE
- Generic name
- FELBAMATE
- Active ingredients
- FELBAMATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TARO
- Manufacturer
- Taro Pharmaceuticals U.S.A., inc.
- First approval
- 2017-04-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown